Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19.
Betacoronavirus
/ isolation & purification
COVID-19
Comorbidity
Coronavirus Infections
/ complications
Correlation of Data
Echocardiography
/ methods
Female
Hospitalization
/ statistics & numerical data
Humans
Hypertension, Pulmonary
/ diagnosis
Italy
/ epidemiology
Male
Middle Aged
Outcome Assessment, Health Care
Pandemics
Pneumonia, Viral
/ complications
Prevalence
SARS-CoV-2
Severity of Illness Index
Ventricular Dysfunction, Right
/ diagnosis
echocardiography
pulmonary vascular disease
Journal
Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
14
05
2020
revised:
30
06
2020
accepted:
01
07
2020
pubmed:
18
7
2020
medline:
26
8
2020
entrez:
18
7
2020
Statut:
ppublish
Résumé
To assess the prevalence, characteristics and prognostic value of pulmonary hypertension (PH) and right ventricular dysfunction (RVD) in hospitalised, non-intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19). This single-centre, observational, cross-sectional study included 211 patients with COVID-19 admitted to non-ICU departments who underwent a single transthoracic echocardiography (TTE). Patients with poor acoustic window (n=11) were excluded. Clinical, imaging, laboratory and TTE findings were compared in patients with versus without PH (estimated systolic pulmonary artery pressure >35 mm Hg) and with versus without RVD (tricuspid annular plane systolic excursion <17 mm or S wave <9.5 cm/s). The primary endpoint was in-hospital death or ICU admission. A total of 200 patients were included in the final analysis (median age 62 (IQR 52-74) years, 65.5% men). The prevalence of PH and RVD was 12.0% (24/200) and 14.5% (29/200), respectively. Patients with PH were older and had a higher burden of pre-existing cardiac comorbidities and signs of more severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (radiological lung involvement, laboratory findings and oxygenation status) compared with those without PH. Conversely, patients with RVD had a higher burden of pre-existing cardiac comorbidities but no evidence of more severe SARS-CoV-2 infection compared with those without RVD. The presence of PH was associated with a higher rate of in-hospital death or ICU admission (41.7 vs 8.5%, p<0.001), while the presence of RVD was not (17.2 vs 11.7%, p=0.404). Among hospitalised non-ICU patients with COVID-19, PH (and not RVD) was associated with signs of more severe COVID-19 and with worse in-hospital clinical outcome. NCT04318366.
Identifiants
pubmed: 32675217
pii: heartjnl-2020-317355
doi: 10.1136/heartjnl-2020-317355
pmc: PMC7476272
doi:
Banques de données
ClinicalTrials.gov
['NCT04318366']
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1324-1331Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Crit Care Med. 2001 Aug;29(8):1551-5
pubmed: 11505125
Chest. 2007 Aug;132(2):410-7
pubmed: 17573487
N Engl J Med. 1977 Mar 3;296(9):476-80
pubmed: 834225
Intensive Care Med. 1998 Oct;24(10):1018-28
pubmed: 9840234
Intensive Care Med. 2006 Jun;32(6):852-7
pubmed: 16614811
Eur Respir J. 2003 Apr;21(4):720-7
pubmed: 12762363
Braz J Med Biol Res. 2014 Oct;47(10):904-10
pubmed: 25118626
Int J Cardiol. 2020 Jul 15;311:116-121
pubmed: 32291207
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Crit Care Resusc. 2020 Apr 01;22(2):91-94
pubmed: 32227819
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Crit Care Resusc. 2020 Apr 15;22(2):95-97
pubmed: 32294809
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Curr Opin Crit Care. 2003 Feb;9(1):15-21
pubmed: 12548024
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Physiol Rev. 2012 Jan;92(1):367-520
pubmed: 22298659
Anesthesiology. 1990 Jun;72(6):966-70
pubmed: 2190501
Radiology. 2020 Aug;296(2):E72-E78
pubmed: 32216717
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JACC Cardiovasc Imaging. 2020 Apr 28;:
pubmed: 32654963
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Pulm Circ. 2018 Jan-Mar;8(1):2045893217753415
pubmed: 29283029
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
J Am Soc Echocardiogr. 2013 Jan;26(1):1-14
pubmed: 23140849